Efficacy of oral micronized progesterone when applied via vaginal route
- PMID: 15222511
Efficacy of oral micronized progesterone when applied via vaginal route
Abstract
The aim of the study was to compare the efficacy of oral micronized progesterone when applied by the vaginal route. The comparative study of serum progesterone levels between oral and vaginal micronized progesterone administration was conducted in sixty female volunteers. The subjects were equally divided into two groups to receive the drug either via the oral or vaginal route. The subjects' profiles showed that there was no significant difference in general characteristics between these two groups. The blood tests for estrogen and progesterone levels were performed on all volunteers before and after the drug administration. The data collected from the experiment revealed that the serum progesterone levels achieved by oral administration (5.06 +/- 2.95 ng/ml) differed significantly (p < 0.001) from those achieved by vaginal administration (8.26 +/- 4.09 ng/ml). The data also revealed that the serum progesterone levels of the oral administration group (4.23 +/- 2.68 ng/ml) did not differ significantly (p = 0.925) from the other group (4.15 +/- 3.40 ng/ml) when the serum estrogen level was less than 30 pg/ml. On the contrary, when the serum estrogen level was at least 30 pg/ml, there was a significant (p < 0.005) difference in the serum progesterone levels between these two groups (6.32 +/- 2.99 ng/ml for the oral route and 9.76 +/- 3.23 ng/ml for the vaginal route).
Similar articles
-
Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.Hum Reprod. 2007 May;22(5):1260-3. doi: 10.1093/humrep/del520. Epub 2007 Jan 16. Hum Reprod. 2007. PMID: 17227809 Clinical Trial.
-
Bioavailability of progesterone with different modes of administration.J Reprod Med. 1987 Jun;32(6):443-8. J Reprod Med. 1987. PMID: 3612635
-
Efficacy of oral micronized progesterone in the treatment of luteal phase defects.J Reprod Med. 1995 Jul;40(7):521-4. J Reprod Med. 1995. PMID: 7473442
-
Micronized progesterone: vaginal and oral uses.Clin Obstet Gynecol. 1995 Dec;38(4):902-14. Clin Obstet Gynecol. 1995. PMID: 8616985 Review. No abstract available.
-
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.
Cited by
-
Luteal phase support for assisted reproduction cycles.Cochrane Database Syst Rev. 2015 Jul 7;2015(7):CD009154. doi: 10.1002/14651858.CD009154.pub3. Cochrane Database Syst Rev. 2015. PMID: 26148507 Free PMC article.